Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer02:18

Cancer

55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
Standards of Care II01:19

Standards of Care II

1.2K
Nurses bear specific legal responsibilities under several federal statutes, including:
1.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis and Staging of Patients with Prostate Cancer: Report from the 2025 Advanced Prostate Cancer Consensus Conference (APCCC) Diagnostics.

European urology·2026
Same author

177Lutetium-PSMA-I&T therapy for metastatic castration-resistant prostate cancer (mCRPC): the first multicenter real-world study of 177Lu-PSMA-I&T in Brazil.

EJNMMI reports·2026
Same author

Prostate Cancer Treatment Patterns and Inequities Among Racial Groups in Brazil's Public Health System: Insights From a 16-Year Real-World Study.

JCO global oncology·2026
Same author

Adrenal neuroblastoma in adult: case report.

Urology case reports·2026
Same author

Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study.

JCO global oncology·2026
Same author

Liquid-based genomic profiling in high-risk localized prostate cancer.

Frontiers in urology·2026
Same journal

Extraperitoneal Single-Port Robotic-Assisted Radical Cystectomy with Orthotopic Ne-obladder: Technique and Surgical Considerations.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Robot-Assisted Partial Nephrectomy in a High-Complexity Renal Tumor in a Horseshoe Kidney.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Safety and Efficacy of the SHURUI Single-Port Robot-Assisted System via Transmesenteric Approach for Pyeloplasty in Upper Ureteral Stricture: A Single-Center Prospective Cohort Study.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Energy sources in percutaneous surgery. Are lasers ready to become the gold standard? A narrative review.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

Quality of life: a neglected aspect in male infertility studies.

International braz j urol : official journal of the Brazilian Society of Urology·2026
Same journal

cN2-cN3 Penile Squamous Cell Carcinoma: Patient Selection, Treatment Delivery, and Real-World Challenges.

International braz j urol : official journal of the Brazilian Society of Urology·2026
See all related articles

Related Experiment Video

Updated: Mar 7, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K

First Brazilian Consensus of Advanced Prostate Cancer: Recommendations for Clinical Practice.

Andre Deeke Sasse1, Evanius Garcia Wiermann2, Daniel Herchenhorn3

  • 1Clínica Médica, Unicamp, Campinas, SP, Brasil.

International Braz J Urol : Official Journal of the Brazilian Society of Urology
|February 16, 2017
PubMed
Summary
This summary is machine-generated.

This consensus provides recommendations for advanced prostate cancer treatment, addressing therapy choices and sequencing to improve disease control. Experts reached consensus on several issues, highlighting areas needing more evidence.

Keywords:
DiagnosisPractice Guideline [Publication Type]Prostatic Neoplasms

More Related Videos

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

1.8K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.3K

Related Experiment Videos

Last Updated: Mar 7, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
06:08

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

1.8K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.3K

Area of Science:

  • Oncology
  • Urology

Background:

  • Advanced prostate cancer affects 20% of patients, often without curative options.
  • Therapeutic approaches for metastatic prostate cancer remain heterogeneous despite advances.

Purpose of the Study:

  • To summarize the I Brazilian Consensus on Advanced Prostate Cancer.
  • To provide expert recommendations on managing metastatic prostate cancer.

Main Methods:

  • Experts selected by Brazilian Society of Urology and Clinical Oncology.
  • Forty controversial issues in advanced prostate cancer were addressed.
  • Consensus reached with a 2/3 participant threshold.

Main Results:

  • Treatment for advanced prostate cancer is complex due to numerous therapies with varied efficacy and toxicity.
  • Recommendations cover preferred therapies, criteria for treatment change, and sequencing strategies.
  • Lack of consensus on some topics indicates insufficient evidence.

Conclusions:

  • The consensus aims to optimize disease control in advanced prostate cancer.
  • It provides guidance on maximizing the use of available therapeutic options.
  • Identifies areas requiring further research due to evidence gaps.